A

ACADIA Pharmaceuticals
D

ACAD

16.195
USD
-0.09
(-0.52%)
Market Closed
Volume
0
EPS
0
Div Yield
-
P/E
85
Market Cap
2,686,362,662
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    -12.22
    (-4.13%)
    289.88 USD
    BIIB
    BIIB
    -4.840
    (-2.94%)
    160.000 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.48 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    749.9 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.85 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.14 USD
    More
News

Title: ACADIA Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.